Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00018759 · ClinicalTrials.gov registry record · Phase 4
Treatment Effects on Platelet Calcium in Hypertensive and Depressed Patients
A Phase 4 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 4
- Development phase
NCT00018759 is a Phase 4 study that has completed, run by US Department of Veterans Affairs.
The verdict
NCT00018759, a Phase 4 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 4
- Development phase
Study Summary
This study aims to determine if treatment with an SSRI antidepressant medication, paroxetine, is associated with cellular calcium response to serotonin, platelet serotonin receptors, and improvement in mood in depressed patients with or without hypertension. It is hypothesized that platelets of hypertensive patients with depressive symptomatology with be hyper-responsive to serotonin. Additionally, treatment with an SSRI antidepressant is expected to produce a down-regulation of the serotonin receptor with an associated reduction in platelet cytosolic calcium response as well as improved mood.
Interventions
- DRUG paroxetine
- BEHAVIORAL ongoing psychological screening
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-03 |
| Est. Completion | 2003-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00018759
The ClinicalTrials.gov registry entry for NCT00018759 describes a study currently listed as completed, categorized as Phase 4. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which paroxetine is the first listed.
NCT00018759 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00018759 about?
NCT00018759 is a clinical study titled "Treatment Effects on Platelet Calcium in Hypertensive and Depressed Patients". This study aims to determine if treatment with an SSRI antidepressant medication, paroxetine, is associated with cellular calcium response to serotonin, platelet serotonin receptors, and improvement in mood in depressed patients with or without hypertension. It is hypothesized that platelets of hype...
What is the current status of trial NCT00018759?
This trial is currently completed. It is a Phase 4 study. The study started on 2001-03. Estimated completion is 2003-10.
What interventions are being tested in trial NCT00018759?
The interventions under investigation include: paroxetine (DRUG), ongoing psychological screening (BEHAVIORAL).
Who is sponsoring clinical trial NCT00018759?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.